Advertisement

Pain Management

Treatment Rates Low for Parents With Opioid Use Disorder

May 22, 2019

WEDNESDAY, May 22, 2019 (HealthDay News) -- Rates of treatment are low for parents with opioid use disorder (OUD) or other substance use disorders (SUDs), according to a study published in the May/Jun...

Non-Rx Fentanyl Up in Urine Tests Positive for Other Drugs

May 21, 2019

TUESDAY, May 21, 2019 (HealthDay News) -- An increasing number of urine drug test (UDT) results positive for cocaine or methamphetamine are also positive for nonprescribed fentanyl, according to a stu...

Racial Disparity Seen in Prescriptions for Buprenorphine

May 20, 2019

MONDAY, May 20, 2019 (HealthDay News) -- Black patients are less likely to receive a buprenorphine prescription to treat opioid use disorder, according to a research letter published online May 8 in J...

Opioids crisis has spread beyond United States: OECD

May 16, 2019

PARIS (Reuters) - Opioid use has reached crisis proportions not only in the United States but also in Canada and some European countries, as prescription opioid painkillers have become ...

Few black patients get buprenorphine for opioid addiction

May 14, 2019

By Lisa Rapaport (Reuters Health) - While the number of Americans getting drug treatment for opioid addiction is on the rise, a new study suggests that gains may be concen...

Prevalence of Low Back Pain About 26.4 Percent in U.S. Workers

May 13, 2019

MONDAY, May 13, 2019 (HealthDay News) -- The overall prevalence of low back pain (LBP) among U.S. workers is about 26.4 percent, according to a research letter published online May 14 in the Annals of...

Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

May 10, 2019

By Julie Steenhuysen INDIANAPOLIS (Reuters) - Eli Lilly and Co has pulled ahead in a three-way race with Amgen Inc and Teva Pharmaceutical Industries Ltd in attracting new...

Opioid overdose deaths decline when pharmacists can dispense naloxone

May 09, 2019

By Linda Carroll (Reuters Health) - In states where pharmacists were allowed to sell the potentially lifesaving opioid antidote naloxone without a prescription, fewer peop...

Few at risk for opioid overdose get potentially life-saving naloxone

May 03, 2019

By Linda Carroll (Reuters Health) - A tiny percentage of people at high risk for opioid overdose are getting prescriptions for naloxone, a medication that could potentiall...

Founder, execs of drug company guilty in conspiracy that fed opioid crisis

May 02, 2019

By Nate Raymond BOSTON (Reuters) - The founder of Insys Therapeutics Inc on Thursday became the highest-ranking pharmaceutical executive to be convicted in a case tied to ...

McKesson to pay $37 million to resolve West Virginia opioid lawsuit

May 02, 2019

By Nate Raymond (Reuters) - Drug distributor McKesson Corp has agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold it responsible ...

Teens with chronic pain may find support on YouTube

May 01, 2019

By Manas Mishra (Reuters Health) - Teens with painful chronic illnesses may find that YouTube can provide a support network, a new study suggests. ...

April 2019 Briefing - Anesthesiology

May 01, 2019

Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for April 2019. This roundup includes the latest research news from journal articles, as well as...

April 2019 Briefing - Pain Management

May 01, 2019

Here are what the editors at HealthDay consider to be the most important developments in Pain Management for April 2019. This roundup includes the latest research news from journal articles, as well a...

Teva stops testing its migraine drug as cluster headache treatment

Apr 23, 2019

By Manas Mishra (Reuters) - Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches after the ...

FDA approves Teva's generic nasal spray to treat opioid overdose

Apr 19, 2019

(Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval from the U.S. Food and Drug Administration (FDA) to market its generic nasal spray for opioi...

Acetaminophen Safe as First-Line Analgesic for Most Older Adults

Apr 19, 2019

FRIDAY, April 19, 2019 (HealthDay News) -- Despite a potential increased risk for stroke in patients with diabetes, acetaminophen is a safe first-line analgesic for most older adults living in nursing...

U.S. launches four-state study to find ways to reduce opioid overdose deaths

Apr 18, 2019

By Manas Mishra and Tamara Mathias (Reuters) - U.S. health officials on Thursday said they will spend $350 million in four states to study ways to best deal with the natio...

Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study

Apr 18, 2019

(Reuters) - A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet main goals in a late-stage study in patients with moderate-to-severe osteoa...

Curbing Long-term Opioid Use: The Case for Early Physical Therapy

Apr 18, 2019

Early physical therapy (PT) may help reduce the risk of long-term opioid use by serving as an alternative or adjunct to short-term opioid use for patients with various types of musculoskeletal pain. P...

SUBSPECIALTIES

Advertisement